The purpose of this project is to test the hypothesis that hepatitis C virus (HCV) infection persists due to arrested development of CDS T cell-mediated antiviral responses during the ransition from acute to chronic phase by CD4 dependent mechanisms. During the previous funding period we have developed an infrastructure to obtain large numbers of peripheral blood mononuclear cells (PBMC) from acutely-infected individuals, and used overlapping peptides encompassing the entire HCV polyprotein to characterize IFNgamma-mediated immune responses. Most subjects responded to multiple epitopes, with peak recognition around 6 months then decreasing during the following 12-18 months. New specificities were not detected after the first 6 months, despite ongoing amino acid replacements. Amino acid replacements in T cell epitopes frequently represent escape mutants, and most epitopes develop amino acid replacements. We therefore propose to investigate the mechanisms of cellular immune failure during the transition between acute and chronic infection.
Aim 1 : To define molecular markers of CD8+ T lymphocyte failure in PBMC from persons with acute HCV infection. We will determine the timing and breadth of response, measure cell-surface and intracellular markers of CDS phenotype and maturation. We will correlate these findings with responses in lymphocytes obtained from livers in a well-characterized subset of volunteers to assess the degree of compartmentalization.
Aim 2 : To define the role of CD4 T cells in modulating CDS T cell responses to acute HCV infection. The number, phenotype, and compartmentalization of CD4 cells will be investigated. Measures will include TH1/TH2 cytokine expression, cell surface markers of phenotype and regulation, and the temporal relationship of these markers versus CDS function determined in aim 1. The proposed studies will be synergistic with a well-characterized prospective cohort of active injection drug users (see clinical core) from whom clinical, histologic, and virologic information will also be obtained.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI040035-14
Application #
7908846
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
14
Fiscal Year
2009
Total Cost
$290,931
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Jarret, Abigail; McFarland, Adelle P; Horner, Stacy M et al. (2016) Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nat Med 22:1475-1481
Hong, MeeAe; Schwerk, Johannes; Lim, Chrissie et al. (2016) Interferon lambda 4 expression is suppressed by the host during viral infection. J Exp Med 213:2539-2552
Yi, MinKyung; Hu, Fengyu; Joyce, Michael et al. (2014) Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. J Virol 88:3678-94
Li, Kui; Lemon, Stanley M (2013) Innate immune responses in hepatitis C virus infection. Semin Immunopathol 35:53-72
Wilkins, Courtney; Woodward, Jessica; Lau, Daryl T-Y et al. (2013) IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 57:461-9
Horner, Stacy M; Park, Hae Soo; Gale Jr, Michael (2012) Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix ?0. J Virol 86:3112-20
Welsch, Christoph; Schweizer, Sabine; Shimakami, Tetsuro et al. (2012) Ketoamide resistance and hepatitis C virus fitness in val55 variants of the NS3 serine protease. Antimicrob Agents Chemother 56:1907-15
Zhou, Yan; Callendret, BenoƮt; Xu, Dan et al. (2012) Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection. J Exp Med 209:1481-92
Grebely, Jason; Prins, Maria; Hellard, Margaret et al. (2012) Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis 12:408-14
Shimakami, Tetsuro; Yamane, Daisuke; Jangra, Rohit K et al. (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 109:941-6

Showing the most recent 10 out of 156 publications